ETOPOPHOS 100 mg, lyophilizate for parenteral use bottle
Active ingredients: Etoposide, ÉTOPOSIDE (PHOSPHATE D')
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder for solution for infusionbottleintraveineuse
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- ETOPOPHOS 100 mg, lyophilisat pour usage parentéral
- Pharmaceutical form
- poudre pour solution injectable pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 May 1997
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65619363CIP75596500CIP133400955965008Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTOPOSIDEpoudre | 100 mg · un flacon | FT |
| ÉTOPOSIDE (PHOSPHATE D')poudre | 113,60 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.